Archan Khandekar

University of Miami Health System, Kokilaben Dhirubhai Ambani Hospital, University of Miami

Papers

Total Citations

H-Index

About

Archan Khandekar is a urologic oncologist and robotic surgeon whose research focuses on advancing minimally invasive surgery for genitourinary cancers, particularly bladder and renal cell carcinoma. His work has been instrumental in demonstrating the safety and efficacy of robotic radical cystectomy, which he and his colleagues have championed as the standard of care for muscle-invasive bladder cancer. In a 2024 perspective piece in the *Journal of Urology*, Khandekar and co-authors argued that robotic cystectomy offers superior perioperative outcomes and oncologic control, helping to shift the field toward broader adoption of this technique. During the COVID-19 pandemic, he led a study from Mumbai—then a global hotspot—showing that robot-assisted uro-oncology surgery could be performed safely without compromising patient outcomes, a critical finding for maintaining cancer care during public health crises. Khandekar has also investigated racial and ethnic disparities in the use of partial nephrectomy and robotic surgery for renal cell carcinoma, identifying socioeconomic barriers that limit access to nephron-sparing approaches. His work, cited in leading journals, underscores a commitment to both surgical innovation and health equity, making him a rising voice in urologic oncology.